In tumor cells, the low activity M2 isoform of pyruvate kinase M (PKM2) is predominantly expressed instead of PKM1, which is supposed to facilitate anabolic metabolism by the accumulation of upstream glycolytic intermediates and subsequent shunting of these intermediates into anabolic pathways23, 36. Here, PKM is linked to neoplasm.